Results 91 to 100 of about 24,035 (181)

Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011–2016Research in context

open access: yesEBioMedicine, 2019
Background: Historically, the major cause of meningococcal epidemics in the meningitis belt of sub-Saharan Africa has been Neisseria meningitidis serogroup A (NmA), but the incidence has been substantially reduced since the introduction of a serogroup A ...
Nadav Topaz   +13 more
doaj   +1 more source

Post vaccinal temporary sensorineural hearing loss [PDF]

open access: yes, 2018
In our systematic research we identified four studies concerning the onset of neurological adverse events following vaccination and two excluding this association.
De Cesare, Donato Pompeo   +8 more
core   +1 more source

Analysis of TLR2, TLR4, and TLR9 single nucleotide polymorphisms in children with bacterial meningitis and their healthy family members

open access: yesInternational Journal of Infectious Diseases, 2017
Background: The aim was to analyse TLR2 rs5743708, TLR2 rs4696480, TLR4 rs4986790, TLR9 rs5743836, and TLR9 rs352140 single nucleotide polymorphisms (SNPs) in children with pneumococcal and meningococcal meningitis and their family members.
Ewelina Gowin   +6 more
doaj   +1 more source

Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines

open access: yesBulletin of the World Health Organization, 2003
Endemic and epidemic group A meningococcal meningitis remains a major cause of morbidity and mortality in sub-Saharan Africa, despite the availability of the safe and inexpensive group A meningococcal polysaccharide vaccine, which is protective at all ...
Robbins John B.   +7 more
doaj  

Climate Regimes, El Nino-Southern Oscillation and Meningococcal Meningitis Epidemics

open access: yesFrontiers in Public Health, 2015
Meningoccocal meningitis is a major public health problem that kills thousands annuallyin Africa, Europe, North and South America. Occurrence is, however, highest during thedry seasons in Sahel Africa.
Olusegun Steven Ayodele Oluwole
doaj   +1 more source

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine. [PDF]

open access: yes, 2015
BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisseria meningitidis infection. METHODS: Twenty cross-sectional carriage surveys were conducted in 7 countries in the African meningitis belt; 5 surveys were ...
MenAfriCar consortium
core   +3 more sources

A case report of multiple cerebral abscess formation complicating serogroup B Neisseria meningitidis meningitis

open access: yesBMC Infectious Diseases, 2019
Background Invasive meningococcal disease (IMD) presenting with meningitis causes significant mortality and morbidity. Suppurative complications of serogroup B meningococcal sepsis are rare and necessitate urgent multidisciplinary management to mitigate ...
Ciara O’Connor   +5 more
doaj   +1 more source

Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxis [PDF]

open access: yes, 2017
Background The annual Muslim pilgrimage has the potential of increase risk for acquisition of Neisseria meningitidis. Here, we evaluate the Hajj impact on the prevalence of N.
Abdallah Assiri   +9 more
core   +1 more source

Pharyngeal carriage of Neisseria species in the African meningitis belt. [PDF]

open access: yes, 2016
OBJECTIVES: Neisseria meningitidis, together with the non-pathogenic Neisseria species (NPNs), are members of the complex microbiota of the human pharynx.
Ali, Oumer A   +31 more
core   +1 more source

Meningococcal carriage in the African meningitis belt. [PDF]

open access: yes, 2013
A meningococcal serogroup A polysaccharide/tetanus toxoid conjugate vaccine (PsA-TT) (MenAfriVac(™) ) is being deployed in countries of the African meningitis belt.
MenAfriCar Consortium
core   +1 more source

Home - About - Disclaimer - Privacy